netFormulary The Pennine Acute Hospitals NHS
NHS Trust Formulary  
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Section
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
08.01 Cytotoxic drugs (0,0)
Side-effects of cytotoxic drugs (0,1)
Drugs for cytotoxic-induced side-effects (3,4)
08.01.01 Alkylating drugs (0,0)
08.01.02 Anthracyclines and other cytotoxic antibiotics (0,0)
08.01.03 Antimetabolites (0,0)
08.01.04 Vinca alkaloids and etoposide (0,0)
08.01.05 Other antineoplastic drugs (0,0)
Hydroxycarbamide (1,0)
08.02 Drugs affecting the immune response (0,0)
Immunosuppressant therapy (0,0)
08.02.01 Antiproliferative immunosuppressants (4,0)
08.02.02 Other immunosuppressants (2,4)
08.02.03 Anti-lymphocyte monoclonal antibodies (4,0)
08.02.04 Other immunomodulating drugs (0,7)
Interferon Alfa (4,0)
Interferon beta (0,5)
Interferon gamma (0,0)
Aldesleukin (0,1)
BCG bladder instillation (1,1)
Canakinumab (0,0)
Dimethyl fumarate (0,0)
Fingolimod (0,0)
Glatiramer acetate (0,1)
Histamine (0,0)
Lenalidomide, pomalidomide, and thalidomide (3,0)
Mifamurtide (0,1)
Natalizumab (0,1)
Teriflunomide (0,0)
08.03 Sex hormones and hormone antagonists in malignant disease (0,0)
08.03.01 Oestrogens (2,0)
08.03.02 Progestogens (2,0)
08.03.03 Androgens (0,0)
08.03.04 Hormone antagonists (0,0)
08.03.04.01 Breast cancer (5,1)
08.03.04.02 Prostate cancer and gonadorelin analogues (0,0)
Gonadorelin analogues (2,4)
Anti-androgens (2,3)
Gonadotrophin-releasing hormone antagonists (0,1)
08.03.04.03 Somatostatin analogues (2,1)
netFormulary